These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31615790)

  • 41. Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
    Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
    Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome.
    Niessen RC; Hofstra RM; Westers H; Ligtenberg MJ; Kooi K; Jager PO; de Groote ML; Dijkhuizen T; Olderode-Berends MJ; Hollema H; Kleibeuker JH; Sijmons RH
    Genes Chromosomes Cancer; 2009 Aug; 48(8):737-44. PubMed ID: 19455606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.
    Tamura K; Kaneda M; Futagawa M; Takeshita M; Kim S; Nakama M; Kawashita N; Tatsumi-Miyajima J
    Int J Clin Oncol; 2019 Sep; 24(9):999-1011. PubMed ID: 31273487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
    Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
    JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
    Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risks of Lynch syndrome cancers for MSH6 mutation carriers.
    Baglietto L; Lindor NM; Dowty JG; White DM; Wagner A; Gomez Garcia EB; Vriends AH; ; Cartwright NR; Barnetson RA; Farrington SM; Tenesa A; Hampel H; Buchanan D; Arnold S; Young J; Walsh MD; Jass J; Macrae F; Antill Y; Winship IM; Giles GG; Goldblatt J; Parry S; Suthers G; Leggett B; Butz M; Aronson M; Poynter JN; Baron JA; Le Marchand L; Haile R; Gallinger S; Hopper JL; Potter J; de la Chapelle A; Vasen HF; Dunlop MG; Thibodeau SN; Jenkins MA
    J Natl Cancer Inst; 2010 Feb; 102(3):193-201. PubMed ID: 20028993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study.
    Eikenboom EL; Moen S; van Leerdam ME; Papageorgiou G; Doukas M; Tanis PJ; Dekker E; Wagner A; Spaander MCW;
    Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1106-1117. PubMed ID: 37865103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simplified identification of Lynch syndrome: a prospective, multicenter study.
    Bonnet D; Selves J; Toulas C; Danjoux M; Duffas JP; Portier G; Kirzin S; Ghouti L; Carrère N; Suc B; Alric L; Barange K; Buscail L; Chaubard T; Imani K; Guimbaud R
    Dig Liver Dis; 2012 Jun; 44(6):515-22. PubMed ID: 22480969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
    Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
    J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Childhood cancers in families with and without Lynch syndrome.
    Heath JA; Reece JC; Buchanan DD; Casey G; Durno CA; Gallinger S; Haile RW; Newcomb PA; Potter JD; Thibodeau SN; Le Marchand L; Lindor NM; Hopper JL; Jenkins MA; Win AK
    Fam Cancer; 2015 Dec; 14(4):545-51. PubMed ID: 25963852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
    Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
    Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
    Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV
    JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients.
    Ligtenberg MJ; Kuiper RP; Geurts van Kessel A; Hoogerbrugge N
    Fam Cancer; 2013 Jun; 12(2):169-74. PubMed ID: 23264089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uptake and outcomes of small intestinal and urinary tract cancer surveillance in Lynch syndrome.
    DeJesse J; Vajravelu RK; Dudzik C; Constantino G; Long JM; Wangensteen KJ; Valverde KD; Katona BW
    World J Clin Oncol; 2021 Nov; 12(11):1023-1036. PubMed ID: 34909397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The spectrum of Lynch syndrome-associated germ-line mutations in Russia.
    Yanus GA; Akhapkina TA; Iyevleva AG; Kornilov AV; Suspitsin EN; Kuligina ES; Ivantsov AO; Aleksakhina SN; Sokolova TN; Sokolenko AP; Togo AV; Imyanitov EN
    Eur J Med Genet; 2020 Mar; 63(3):103753. PubMed ID: 31491536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early detection of duodenal cancer by upper gastrointestinal-endoscopy in Lynch syndrome.
    Vangala DB; Ladigan-Badura S; Engel C; Hüneburg R; Perne C; Bucksch K; Nattermann J; Steinke-Lange V; Rahner N; Weitz J; Kloor M; Tomann J; Canbay A; Nguyen HP; Strassburg C; Möslein G; Morak M; Holinski-Feder E; Büttner R; Aretz S; Löffler M; Schmiegel W; Pox C; Schulmann K;
    Int J Cancer; 2021 Dec; 149(12):2052-2062. PubMed ID: 34331771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a Japanese Lynch syndrome patient with large deletion in the 3' region of the EPCAM gene.
    Eguchi H; Kumamoto K; Suzuki O; Kohda M; Tada Y; Okazaki Y; Ishida H
    Jpn J Clin Oncol; 2016 Feb; 46(2):178-84. PubMed ID: 26613680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of germline genetic mutations in patients with pancreatic cancer.
    Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
    Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative study of quantitative immunohistochemistry and quantum dot immunohistochemistry for mutation carrier identification in Lynch syndrome.
    Barrow E; Evans DG; McMahon R; Hill J; Byers R
    J Clin Pathol; 2011 Mar; 64(3):208-14. PubMed ID: 21177748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cumulative risks of colorectal cancer in Han Chinese patients with Lynch syndrome in Taiwan.
    Kamiza AB; Wang WC; You JF; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; Hsiung CA; Yeh CC
    Sci Rep; 2021 Apr; 11(1):8899. PubMed ID: 33903664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.